Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Proactive research analyst says Tiziana Life Sciences "moving forward quite nicely" By: TheNewswire.com February 09, 2023 at 05:24 AM EST Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a 2023 Clinical Outlook for clinical stage biotechnology company Tiziana Life Sciences Ltd (NASDAQ:TLSA). He gives his take on what the market can expect from the business this year, saying that it is now "moving forward quite nicely." Contact DetailsProactive UK LtdProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Proactive research analyst says Tiziana Life Sciences "moving forward quite nicely" By: TheNewswire.com February 09, 2023 at 05:24 AM EST Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a 2023 Clinical Outlook for clinical stage biotechnology company Tiziana Life Sciences Ltd (NASDAQ:TLSA). He gives his take on what the market can expect from the business this year, saying that it is now "moving forward quite nicely." Contact DetailsProactive UK LtdProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.com
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a 2023 Clinical Outlook for clinical stage biotechnology company Tiziana Life Sciences Ltd (NASDAQ:TLSA). He gives his take on what the market can expect from the business this year, saying that it is now "moving forward quite nicely." Contact DetailsProactive UK LtdProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.com
